Pacing Strategies for Chronotropic Incompetence in AF and HF

Chronotropic incompetence is the inability to increase the heart rate appropriately during activity. In patients with atrial fibrillation (AF) and heart failure (HF), it can arise from sinus-node disease, atrioventricular conduction abnormalities, medication effects, autonomic dysfunction, or the haemodynamic consequences of AF itself. Breathlessness, fatigue and reduced exercise tolerance may therefore reflect several overlapping mechanisms.

Pacing decisions should be guided by the patient’s rhythm pattern, left ventricular function, symptom burden and treatment goals. A carefully selected pacing system can support rate response, preserve ventricular synchrony or guarantee effective cardiac resynchronisation, but an inappropriate mode or programming strategy may worsen congestion, promote right ventricular dyssynchrony or provide little functional benefit.

Establishing The Mechanism Of Exercise Limitation

Chronotropic incompetence is easiest to recognise in sinus rhythm through an exercise test, where the heart rate fails to rise in proportion to metabolic demand. A blunted chronotropic index, inadequate heart-rate reserve and reproduction of symptoms during exertion can strengthen the diagnosis. However, beta-blockers, ivabradine, amiodarone, digoxin, deconditioning, pulmonary disease and anaemia can produce similar findings.

AF complicates interpretation because the ventricular response is irregular and may already be rapid at rest. In permanent AF, a slow or inadequately variable ventricular rate may indicate conduction disease or excessive atrioventricular nodal blockade. In paroxysmal AF, the patient may alternate between sinus-node dysfunction and periods of rapid AF, creating a tachycardia–bradycardia pattern. Ambulatory monitoring, device interrogation and exercise assessment should be interpreted together rather than in isolation.

A practical evaluation also includes echocardiography, assessment of congestion, renal function, iron status and medication review. In Australia, access to formal cardiopulmonary exercise testing is concentrated in larger services in Sydney, Melbourne, Brisbane and other metropolitan centres, so a structured walk test with continuous rhythm observation may be useful when specialist testing is not immediately available.

Matching The Pacing Mode To The Rhythm

For patients with permanent AF and symptomatic bradycardia, a rate-responsive ventricular pacemaker is often the most straightforward option. A VVIR system can increase ventricular pacing rate according to sensed movement or physiological signals, although its benefit depends on how much intrinsic ventricular conduction remains and whether the sensor reflects the patient’s true activity.

Atrial-based or dual-chamber pacing may be preferable when sinus rhythm is present for meaningful periods, particularly in patients with paroxysmal AF and sinus-node dysfunction. It can preserve atrioventricular synchrony during sinus rhythm and provide mode switching during atrial tachyarrhythmias. Programming should avoid unnecessary right ventricular pacing when intrinsic conduction is reliable, while still preventing clinically important pauses.

The phrase pacing strategies for chronotropic incompetence in patients with atrial fibrillation and heart failure covers several distinct clinical situations. A patient with permanent AF and preserved ejection fraction does not have the same pacing needs as someone with reduced ejection fraction, a high ventricular pacing burden and recurrent decompensation. Device selection should therefore follow the rhythm phenotype rather than the diagnostic label alone.

Using Rate-Adaptive Pacing Thoughtfully

Rate-adaptive pacing relies on sensors that estimate activity or physiological demand. Accelerometer-based sensors respond quickly to walking and other movement, while minute-ventilation sensors may better reflect sustained exertion but can be affected by respiratory disease or unusual breathing patterns. Combining sensors may improve responsiveness, though complexity can make optimisation more difficult.

Initial programming should establish an appropriate lower rate, upper sensor rate, activity threshold and response factor. A patient who becomes breathless while walking uphill may need a different profile from someone whose symptoms occur during household tasks or rehabilitation. The aim is a physiologically useful rate increase, not the highest possible paced rate.

Rate response should be assessed after implantation through symptom review, stored device data and supervised exertion. Excessive sensor gain can cause unnecessary tachycardia during arm movement, while a threshold that is too high can leave the patient functionally bradycardic. In people with HF, programming should be conservative enough to avoid provoking palpitations or worsening myocardial oxygen demand.

Protecting Ventricular Synchrony

Conventional right ventricular apical pacing can create electrical and mechanical dyssynchrony, particularly when pacing is frequent. This matters in patients with reduced left ventricular ejection fraction, wide QRS complexes or an anticipated high pacing burden. Septal lead placement and algorithms that minimise ventricular pacing may help in selected cases, but they are not substitutes for a resynchronisation strategy when clear indications are present.

Cardiac resynchronisation therapy (CRT) can be appropriate for patients with HF with reduced ejection fraction, ventricular conduction delay and a substantial need for ventricular pacing. In AF, CRT benefit depends heavily on achieving a consistently high percentage of effective biventricular capture. Fusion and pseudofusion beats can make the device-reported pacing percentage appear reassuring when true resynchronisation is incomplete.

Conduction-system pacing, including His-bundle pacing and left bundle branch area pacing, is an expanding alternative. These approaches aim to recruit the native conduction system and may reduce dyssynchrony when standard CRT is difficult or when a high pacing burden is expected. Long-term evidence is still developing, and operator experience, lead stability and local follow-up capacity should influence the choice.

The Australian market includes several TGA-listed pacing and CRT platforms, but availability varies between public hospitals, private electrophysiology practices and regional services. Procurement policies, lead extraction capability and access to specialised device clinics should be considered before selecting a system that may require complex troubleshooting.

Considering Atrioventricular Node Ablation

Some patients with permanent AF and HF remain symptomatic because rapid, irregular conduction persists despite medication. When rate control is inadequate or poorly tolerated, atrioventricular node ablation followed by permanent pacing can create reliable ventricular rate control. It is an irreversible strategy, so the need for lifelong pacing and continued anticoagulation must be explained clearly.

CRT is generally favoured over isolated right ventricular pacing when systolic function is reduced or a high pacing burden is expected. Conduction-system pacing may be considered in selected patients, depending on QRS characteristics, anatomy and local expertise. The objective is to deliver consistent ventricular activation while preventing the rapid conduction that has limited medical therapy.

Before ablation, clinicians should confirm that symptoms are genuinely related to uncontrolled ventricular response and not primarily caused by congestion, pulmonary disease, valvular pathology or inadequate rehabilitation. Device programming immediately after ablation also requires care, because abrupt dependence on pacing and changes in autonomic balance can affect haemodynamics.

Integrating Arrhythmia And Heart Failure Care

AF management does not end when a pacemaker is implanted. Anticoagulation remains guided by thromboembolic risk, and pacing does not remove the need to assess rate control, rhythm-control options or catheter ablation. Guideline-directed HF therapy should be maintained whenever tolerated, with attention to blood pressure, renal function, potassium and changes in exercise capacity.

The ECG and imaging context can reveal additional electrical disease that affects risk assessment. For example, clinicians reviewing unexplained syncope, ventricular arrhythmia or unusual ST-segment patterns may find useful background in this discussion of J-wave syndromes. Such findings do not automatically determine the pacing indication, but they may alter monitoring and sudden-death prevention decisions.

Medication reduction can sometimes improve chronotropic response, particularly when beta-blockade is excessive for the patient’s current haemodynamic state. Any adjustment must balance rate control, ischaemic protection and HF benefit. A multidisciplinary plan involving electrophysiology, HF specialists, pharmacists, physiologists and cardiac rehabilitation staff is often more effective than device programming alone.

Building Follow-Up Around Real-World Access

Follow-up should assess symptoms during the activities that matter to the patient, including walking, stair climbing, shopping and work. Device interrogation can review rate histograms, sensor-driven pacing, biventricular capture, atrial arrhythmia burden and lead performance. Echocardiography is useful when symptoms change, pacing burden rises or ventricular function fails to improve.

Remote monitoring can reduce unnecessary travel, which is particularly valuable for patients in regional New South Wales, Queensland, Western Australia and the Northern Territory. It cannot replace physical assessment when there is suspected lead malfunction, infection, syncope or worsening HF. Clear escalation pathways are important because local hospital capabilities and device expertise differ widely.

Australian services should also account for public and private funding pathways, waiting times and travel costs. Culturally safe communication is essential for Aboriginal and Torres Strait Islander patients, especially when repeated metropolitan visits are required. Written plans should explain wound care, magnet precautions, driving advice, emergency symptoms and how to contact the device clinic.

Exercise rehabilitation can be tailored after programming stabilises. A supervised programme may expose an inadequate upper sensor rate, delayed response or excessive pacing that is not apparent during a resting consultation. Reviewing progress at several weeks and again after medication or HF status changes helps keep the pacing strategy aligned with the patient’s changing physiology.

For clinicians, researchers and trainees, the Journal of Arrhythmia provides a setting to follow emerging evidence on AF, HF, CRT, conduction-system pacing and implantable device care. Readers developing a case series, review or original study can use the journal’s contact information to identify the appropriate editorial pathway.

Selecting a pacing strategy requires more than choosing a device model. Confirm the mechanism of exercise intolerance, define the rhythm pattern, protect ventricular synchrony and programme the system around real activity. Apply the same discipline to follow-up, with objective device data, HF surveillance and access-sensitive care. Sharing well-designed clinical research and carefully documented experience will help refine pacing practice for Australian patients and the wider Asia-Pacific community.